32
In band
Moving averages
SMA 200$1.12-37.66%
Company profile
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$81.49M
P/E ratioNone
EPS$-0.17
Beta1.8
Dividend yield0.00%
52-week high$2.00
52-week low$0.55
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
HRTX
Heron Therapeutics Inc
RSI 37
IMUX
Immunic Inc
RSI 40
IBIO
iBio Inc
RSI 35
SAVA
Cassava Sciences Inc
CRBU
Caribou Biosciences Inc
RSI 23
NERV
Minerva Neurosciences Inc
RSI 32
RSI alerts for CGTX
An email when CGTX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:07 PM EDT